🔎 Trials Near Me

Почетна › Гојазност › Kanzas

Kliničke studije za Гојазност u državi Kanzas

27 studija za Гојазност traži učesnike na lokacijama u državi Kanzas.

Gradovi u državi Kanzas

Zvanični tekst studije (na engleskom)

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

  • AMR Clinical Wichita, Wichita
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07685808

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  • Johnson County Clinical Trials, Lenexa
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT07575399

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

  • Elevate Clinical Research, Wichita
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Cotton O'Neil Clinical Research Center, Topeka
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07794579

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Cotton O'Neil Diabetes & Endocrinology, Topeka
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • AMR Clinical, Newton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07353931

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, El Dorado
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Lenexa
  • Research Site, Newton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Wichita
Тражи се учесникФаза 3Здраве особе су добродошле
Узраст од 18 до 79 · Оба пола · Ажурирано 20. 10. 2026. · NCT07654374

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • Cotton O'Neil Diabetes & Endocrinology, Topeka
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07589608

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • Cotton O'Neil Diabetes & Endocrinology, Topeka
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • JCCT- Juno Northwest Houston, Lenexa
  • Alliance for Multispecialty Research Newton, Newton
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • JCCT- Juno Northwest Houston, Lenexa
  • Alliance for Multispecialty Research Newton, Newton
  • Alliance for Multispecialty Research LLC, Wichita
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • Cotton O'Neil Clinical Research Center, Topeka
Тражи се учесникФаза 3
Узраст од 8 до 18 · Оба пола · Ажурирано 30. 9. 2026. · NCT07253285

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • Cotton O'Neil Clinical Research Center, Topeka
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07321886

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Kansas City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Kansas City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743463

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

  • ICON Early Phase Services, LLC, Lenexa
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 55 · Оба пола · Ажурирано 4. 9. 2026. · NCT07767175

Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities

  • University of Kansas Medical Center, Kansas City
Тражи се учесник
Узраст од 18 до 35 · Оба пола · Ажурирано 11. 8. 2026. · NCT06961591

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Wichita
Тражи се учесникФаза 3
Узраст од 18 до 79 · Оба пола · Ажурирано 10. 8. 2026. · NCT07654361

Gestational Response, Outcomes, and Weight After GLP-1 Use

  • University of Kansas Medical Center, Kansas City
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 18 до 45 · Жене · Ажурирано 4. 8. 2026. · NCT07743567

A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity

  • ICON Early Phase Services, LLC, Lenexa
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 55 · Оба пола · Ажурирано 29. 7. 2026. · NCT07437079

Changes in Body Composition Including Muscle With Anti-Obesity Medications, Both With and Without Exercise

  • University of Kansas Medical Center, Kansas City
Тражи се учесник
Узраст од 18 до 64 · Оба пола · Ажурирано 15. 7. 2026. · NCT07698145

Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)

  • University of Kansas Medical Center, Kansas City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 2. 7. 2026. · NCT06640179

Muscle and Movement With Anti-Obesity Medications

  • University of Kansas Medical Center, Kansas City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 11. 5. 2026. · NCT06645470

A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

  • Altasciences Clinical Kansas, Inc., Overland Park
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 21. 4. 2026. · NCT07395687

Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.

  • University of Kansas Medical Center, Kansas City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 9. 1. 2026. · NCT06636773

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.